Highlighted Text from PDF - Enhanced Version
============================================================
Source file: 3) Parkinson's Disease.pdf
Extraction date: 2025-06-25 20:17:28
Number of extracted texts: 55
============================================================

[1] Page 1 - Method: Drawing
--------------------------------------------------
Dopamine Replacement the
Levodopa – Glod Standard
Color: (1.0, 1.0, 0.0)
--------------------------------------------------

[2] Page 1 - Method: Drawing
--------------------------------------------------
Levodopa – Glod Standard 
Levodopa converted to dopamine in dopaminergic terminals by dopa-decarboxylase
Color: (1.0, 1.0, 0.0)
--------------------------------------------------

[3] Page 1 - Method: Drawing
--------------------------------------------------
Levodopa converted to dopamine in dopaminerg
Directly dopaminergic effect (especially D2 rec.)
Color: (1.0, 1.0, 0.0)
--------------------------------------------------

[4] Page 1 - Method: Drawing
--------------------------------------------------
Directly dopaminergic effect (especially D2 rec.) 
Combine with Carbidopa which is a dopamine decarboxylase inhibitör that prevents the
Color: (1.0, 1.0, 0.0)
--------------------------------------------------

[5] Page 1 - Method: Drawing
--------------------------------------------------
Combine with Carbidopa which is a dopamine decarboxylase inhibitör that p
conversion before Levodopa cross the BBB, note: Carbidopa cant cross BBB
Color: (1.0, 1.0, 0.0)
--------------------------------------------------

[6] Page 1 - Method: Drawing
--------------------------------------------------
conversion before Levodopa cross the BBB, note: Ca
This combination causes: Side effects ↓, efficacy ↑
Color: (1.0, 1.0, 0.0)
--------------------------------------------------

[7] Page 1 - Method: Drawing
--------------------------------------------------
ContraindicaRons:
Color: (1.0, 1.0, 0.0)
--------------------------------------------------

[8] Page 1 - Method: Drawing
--------------------------------------------------
1) Malign melanOma: levOdOpa is a precursor of melanin
Color: (1.0, 1.0, 0.0)
--------------------------------------------------

[9] Page 1 - Method: Drawing
--------------------------------------------------
1) Malign melanOma: levOdOpa is a precursor of melanin 
2) NarrOw-angle glaucOma: levOdOpa with caution as it can increase ocular pressure
Color: (1.0, 1.0, 0.0)
--------------------------------------------------

[10] Page 1 - Method: Drawing
--------------------------------------------------
mine Agonists 
 Pramipexole,
Color: (1.0, 1.0, 0.0)
--------------------------------------------------

[11] Page 1 - Method: ColoredText
--------------------------------------------------
Parkinson’s disease
Color: 16711680
--------------------------------------------------

[12] Page 1 - Method: ColoredText
--------------------------------------------------
2 Types of symptoms:
--------------------------------------------------

[13] Page 1 - Method: ColoredText
--------------------------------------------------
Motor symptoms: almost all due to loss of dopamine neurons in the midbrain
--------------------------------------------------

[14] Page 1 - Method: ColoredText
--------------------------------------------------
Non-motor symptoms: almost all due to nervous dysfunction not related to dopamine
--------------------------------------------------

[15] Page 1 - Method: ColoredText
--------------------------------------------------
neurons. Exmples are: Cognitive impairment,
--------------------------------------------------

[16] Page 1 - Method: ColoredText
--------------------------------------------------
Acetylcholine and Dopamine is impaires (Dopamine
--------------------------------------------------

[17] Page 1 - Method: ColoredText
--------------------------------------------------
decrease so Acetylcholine become overactive)
--------------------------------------------------

[18] Page 1 - Method: ColoredText
--------------------------------------------------
Dopamine Replacement therapy
--------------------------------------------------

[19] Page 1 - Method: ColoredText
--------------------------------------------------
Levodopa
--------------------------------------------------

[20] Page 1 - Method: ColoredText
--------------------------------------------------
Glod Standard
--------------------------------------------------

[21] Page 1 - Method: ColoredText
--------------------------------------------------
Levodopa converted to dopamine in dopaminergic terminals by dopa-decarboxylase
--------------------------------------------------

[22] Page 1 - Method: ColoredText
--------------------------------------------------
Directly dopaminergic effect (especially D2 rec.)
--------------------------------------------------

[23] Page 1 - Method: ColoredText
--------------------------------------------------
conversion before Levodopa cross the BBB, note: Carbidopa cant cross BBB
--------------------------------------------------

[24] Page 1 - Method: ColoredText
--------------------------------------------------
This combination
--------------------------------------------------

[25] Page 1 - Method: ColoredText
--------------------------------------------------
Long-Term Complications:
--------------------------------------------------

[26] Page 1 - Method: ColoredText
--------------------------------------------------
Wearing-off -> Shortened duraNon of action
Color: 16711680
--------------------------------------------------

[27] Page 1 - Method: ColoredText
--------------------------------------------------
On-Off FluctuaRons -> Sudden shins between feeling good and bad (the symptoms)
Color: 16711680
--------------------------------------------------

[28] Page 1 - Method: ColoredText
--------------------------------------------------
Levodopa-Induced Dyskinesia (LID) -> Involuntary, excessive movement
Color: 16711680
--------------------------------------------------

[29] Page 1 - Method: ColoredText
--------------------------------------------------
Better to be taken on an empty stomach thus can reach the brain in 30 min. Can also be
Color: 16711680
--------------------------------------------------

[30] Page 1 - Method: ColoredText
--------------------------------------------------
given inhaled for longer effect.
Color: 16711680
--------------------------------------------------

[31] Page 1 - Method: ColoredText
--------------------------------------------------
Adverse Effects:
--------------------------------------------------

[32] Page 1 - Method: ColoredText
--------------------------------------------------
Nausea, Vomiting, and hemolytic anemia (Autoimmune hemolytic anemia)
--------------------------------------------------

[33] Page 1 - Method: ColoredText
--------------------------------------------------
Malign melan
--------------------------------------------------

[34] Page 1 - Method: ColoredText
--------------------------------------------------
ma: lev
--------------------------------------------------

[35] Page 1 - Method: ColoredText
--------------------------------------------------
pa is a precursor of melanin
--------------------------------------------------

[36] Page 1 - Method: ColoredText
--------------------------------------------------
w-angle glauc
--------------------------------------------------

[37] Page 1 - Method: ColoredText
--------------------------------------------------
ma: levOdOpa with caution as it can increase ocular pressure
--------------------------------------------------

[38] Page 1 - Method: ColoredText
--------------------------------------------------
Dopamine Agonists
--------------------------------------------------

[39] Page 1 - Method: ColoredText
--------------------------------------------------
Deugs: Pramipexole, Ropinirole, Rotigotine, Apomorphine, Pergolide
--------------------------------------------------

[40] Page 1 - Method: ColoredText
--------------------------------------------------
Used for early symptoms
--------------------------------------------------

[41] Page 1 - Method: ColoredText
--------------------------------------------------
NMDA Antagonist
--------------------------------------------------

[42] Page 1 - Method: ColoredText
--------------------------------------------------
Block NMDA receptors (of Gltamate which is also an excitatory neurotransmitter)
--------------------------------------------------

[43] Page 1 - Method: ColoredText
--------------------------------------------------
Used for:
--------------------------------------------------

[44] Page 1 - Method: ColoredText
--------------------------------------------------
1. Prophylaxis and treatment of Influenza A
--------------------------------------------------

[45] Page 1 - Method: ColoredText
--------------------------------------------------
2. Treatment of dyskinesia in patients with Parkinson's disease
--------------------------------------------------

[46] Page 2 - Method: ColoredText
--------------------------------------------------
Drugs that inhibit the breakdown of Dopamine
--------------------------------------------------

[47] Page 2 - Method: ColoredText
--------------------------------------------------
Work on one of 2 enzymes: MAO-B and COMT -> MAO-A for serotonin and MAO-B for
--------------------------------------------------

[48] Page 2 - Method: ColoredText
--------------------------------------------------
dopamine
--------------------------------------------------

[49] Page 2 - Method: ColoredText
--------------------------------------------------
An example of COMT inhibitors is Entacapone and generally given combined with Levadopa
--------------------------------------------------

[50] Page 2 - Method: ColoredText
--------------------------------------------------
and Carbidopa that has a peripheral action on COMT and Tolcapone with Central and
--------------------------------------------------

[51] Page 2 - Method: ColoredText
--------------------------------------------------
peripheral inhibition of COMT
--------------------------------------------------

[52] Page 2 - Method: ColoredText
--------------------------------------------------
Adenosine 2 antagonist
--------------------------------------------------

[53] Page 2 - Method: ColoredText
--------------------------------------------------
Adenosine generally blocks Dopamine
--------------------------------------------------

[54] Page 2 - Method: ColoredText
--------------------------------------------------
AnRcholinergic agents
--------------------------------------------------

[55] Page 2 - Method: ColoredText
--------------------------------------------------
Side effects: dry mouth, sedaNon, mood changes, mental slowness, blurred vision
Color: 16711680
--------------------------------------------------

